{"sourcedb":"DevicePMAs@therightstef","sourceid":"P030035_S003","text":"Approval for the frontier cardiac resynchronization therapy system.  These devices are indicated for:  1) maintaining synchrony of the left and right ventricles in patients who have undergone an av nodal ablation for chronic atrial fibrillation and have nyha class ii or iii heart failure. 2) the reduction of the symptoms of moderate to severe heart failure (nyha class iii or iv) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction \u003C=35% and a prolonged qrs duration.","project":"consensus_PMA_Age_Indications"}